BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 603887)

  • 1. [Porphyria cutanea tarda treated with low doses of antimalarial agents; liver findings (author's transl)].
    Chlumský J; Dobiás J; Chlumská A; Malina L
    Cas Lek Cesk; 1977 Nov; 116(45):1404-6. PubMed ID: 603887
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chloroquine in the treatment of porphyria cutanea tarda symptomatica. Twelve years of experience in 307 patients (author's transl)].
    Kordac V; Martásek P; Kaláb M; Semrádová M; Papezová R
    Cas Lek Cesk; 1981 Oct; 120(40):1225-7. PubMed ID: 7344792
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term treatment of porphyria cutanea tarda with low chloroquine doses.
    Holvay E
    Ther Hung; 1981; 29(1):42-6. PubMed ID: 7188240
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term effect of high-dose, short-course chloroquine therapy on porphyria cutanea tarda.
    Tsega E
    Q J Med; 1987 Nov; 65(247):953-7. PubMed ID: 3455550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of chloroquine in porphyria cutanea tarda].
    Herrero C; Muniesa A
    Med Cutan Ibero Lat Am; 1980; 8(4-6):139-45. PubMed ID: 7024672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of porphyria cutanea tarda using chloroquine].
    Horkay I; Nagy E
    Z Hautkr; 1978 Jun; 53(12):417-21. PubMed ID: 676418
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of porphyria cutanea tarda with intermittent chloroquine].
    Raff M; Formanek I
    Hautarzt; 1980 Aug; 31(8):437-40. PubMed ID: 7451150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Porphyria cutanea tarda and lupus erythematosus].
    Köstler E; Heinicke HJ; Schneider F; Riedel H; Hensel J
    Z Gesamte Inn Med; 1989 Sep; 44(17):527-9. PubMed ID: 2588723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of chloroquine therapy in seven cases of porphyria cutanea tarda: influence on clinical and chemical-clinical pictures (author's transl)].
    Arbosti G; Nava C; Ghezzi I; Grisler R; Brambilla G
    Med Lav; 1979; 70(3):239-47. PubMed ID: 470825
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experience with the therapy of symptomatic liver porphyria using a combination of antimalarial agents--chloroquine with pyrimethamine].
    Zoubek V; Martásek P; Kordac V
    Cas Lek Cesk; 1987 Feb; 126(6):170-3. PubMed ID: 3815471
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of patients with porphyria cutanea tarda with antimalarials].
    Kordac V; Semrádová M
    Cas Lek Cesk; 1973; 112(24):762-5. PubMed ID: 4714507
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of chloroquine treatment of porphyria cutanea tarda on the associated liver disease].
    Wolff Fernández C; Krause Ianpaglia P; Franco Silva C; Armas Merino R
    Rev Invest Clin; 2000; 52(2):211-3. PubMed ID: 10846447
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prolonged low-dose chloroquin therapy of porphyria cutanea tarda].
    Holvay E
    Orv Hetil; 1981 Jul; 122(30):1839-42. PubMed ID: 7301351
    [No Abstract]   [Full Text] [Related]  

  • 14. [Porphyria cutanea tarda: possible treatment and its results (author's transl)].
    Goerz G; Krieg T
    Dtsch Med Wochenschr; 1978 Aug; 103(34):1329-33. PubMed ID: 308001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [2 years' experience with combined therapy of symptomatic liver porphyria using pyrimethamine and chloroquine].
    Kaláb M; Cervinka J; Kotal P; Jirsa M; Kordac V; Marecek Z; Soldátová H; Papezová P
    Cas Lek Cesk; 1988 Mar; 127(10):305-9. PubMed ID: 3365727
    [No Abstract]   [Full Text] [Related]  

  • 16. [Combination therapy of porphyria cutanea tarda using chloroquine and bloodletting therapy].
    Horkay I; Nagy E
    Z Hautkr; 1980 Jun; 55(12):813-6. PubMed ID: 7415362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative evaluation of the therapeutic effectiveness of small and regular doses of delagil in porphyria cutanea tarda].
    Krivosheev BN
    Vestn Dermatol Venerol; 1981 Sep; (9):50-4. PubMed ID: 7029950
    [No Abstract]   [Full Text] [Related]  

  • 18. [Suburoporphyrins in symptomatic hepatic porphyria and in experimental porphyria (author's transl)].
    Kaláb M; Jirsa M; Kordac V; Soldátová H
    Cas Lek Cesk; 1981 Oct; 120(41):1251-4. PubMed ID: 7344798
    [No Abstract]   [Full Text] [Related]  

  • 19. Glucose tolerance in adult Ethiopian patients with liver disease and porphyria cutanea tarda.
    Mengistu M; Gebreselassie F; Tsega E
    Ethiop Med J; 1989 Jul; 27(3):107-14. PubMed ID: 2753029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The liver in Ethiopians with porphyria cutanea tarda.
    Tsega E; Damtew B; Landells JW; Besrat A; Seyoum E
    East Afr Med J; 1982 Oct; 59(10):682-8. PubMed ID: 7185559
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.